ADMA Biologics Inc
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving ADMA Biologics Inc now
Current reporting with the operating signal separated from the noise.
ADMA Biologics Inc (ADMA) Q3 2026 Earnings Call Highlights: Asceniv Surge Drives Margin ...
Investors are testing whether ADMA Biologics Inc’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Earnings To Watch: ADMA Biologics Inc (ADMA) Q3 2026 -- GF Value Sees 102% Upside
Investors are testing whether ADMA Biologics Inc’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Investors heavily search ADMA Biologics Inc (ADMA): Here is what you need to know
The story matters when it changes ADMA Biologics Inc’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest ADMA filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
ADMA Biologics Inc, quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →